The central role of MMP-2 in aneurysm development is underlined by ROC analysis and the discrimination of aneurysmatic from control aortic tissue when active MMP-2 exceeds 10% compared to Pro-MMP-2 can be seen as a starting point for identifying aTAA biomarkers. This evidence concerns the gene MMP2 and aneurysm.